Showing results (1-10 of 47) with videos related to
Sort By:
Pageof 5
The Psychiatric Clinics of North America|September 2, 2022
Thirty Years of TheASAMCriteria: A Report CardDavid R Gastfriend, David Mee-LeeAnnals of the New York Academy of Sciences|September 20, 2014
A pharmaceutical industry perspective on the economics of treatments for alcohol and opioid use disordersDavid R GastfriendAnnals of the New York Academy of Sciences|January 29, 2011
Intramuscular extended-release naltrexone: current evidenceDavid R GastfriendJournal of Psychiatry & Neuroscience : JPN|September 26, 2002
Olanzapine-induced hyperventilation: case reportS Pirzada Sattar, David R GastfriendJournal of Addictive Diseases|July 5, 2005
Reliability of multidimensional substance abuse treatment matching: implementing the ASAM Patient Placement CriteriaSharon L Baker, David R GastfriendThe American Journal of Managed Care|July 19, 2011
Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistenceOnur Baser, Mady Chalk, Richard Rawson, et al.The Journal of Neuropsychiatry and Clinical Neurosciences|March 9, 2002
Addiction denial and cognitive dysfunction: a preliminary investigationWilliam Rinn, Nitigna Desai, Harold Rosenblatt, et al.The American Journal of Managed Care|July 19, 2011
Cost and utilization outcomes of opioid-dependence treatmentsOnur Baser, Mady Chalk, David A Fiellin, et al.Journal of Studies on Alcohol. Supplement|October 15, 2005
Developing a baseline assessment battery: balancing patient time burden with essential clinical and research monitoringDavid R Gastfriend, Dennis Donovan, Rachel Lefebvre, et al.Journal of Addiction Medicine|July 20, 2011
Impact of treatment with intramuscular, injectable, extended-release naltrexone on counseling and support group participation in patients with alcohol dependenceRon A Cisler, Bernard L Silverman, Irina Gromov, et al.Pageof 5